Literature DB >> 10610698

Ratiometric assay of epidermal growth factor receptor tyrosine kinase activation.

K Schooler1, H S Wiley.   

Abstract

Activation of cells is frequently followed by tyrosine phosphorylation of proteins. To quantify this process, we developed a ratiometric enzyme-linked immunosorbent assay (ELISA) using epidermal growth factor receptors (EGFR) as a model. Microtiter dishes were coated with anti-EGFR monoclonal antibodies to capture the receptor followed by parallel detection of receptor and phosphotyrosine content with secondary antibodies. The ratio of these two parameters was found to directly reflect EGFR activation and was insensitive to the effect of receptor downregulation. Our assay could resolve differences in EGFR activation due to small changes (less than 1 ng/ml) in ligand. We found that phosphotyrosine detection by ELISA was 8- to 32-fold more sensitive than Western blot detection and could be reliably detected using as little as 4 ng of cellular lysate. Detection of EGFR levels by ELISA was 30 times more sensitive than Western blot analysis and was reliable for as low as 8 ng of cellular lysate per well. Because of the wide linear range of the ELISA, we could directly compare receptor activation in cell types with different EGFR expression levels. Our assay provides a rapid and sensitive method of determining EGFR activation status and could be easily modified to evaluate any tyrosine-phosphorylated protein. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10610698     DOI: 10.1006/abio.1999.4387

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  7 in total

1.  Antitumor efficacy of cytotoxic drugs and the monoclonal antibody 806 is enhanced by the EGF receptor inhibitor AG1478.

Authors:  Terrance G Johns; Rodney B Luwor; Carmel Murone; Francesca Walker; Janet Weinstock; Angela A Vitali; Rushika M Perera; Achim A Jungbluth; Elisabeth Stockert; Lloyd J Old; Edouard C Nice; Antony W Burgess; Andrew M Scott
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-15       Impact factor: 11.205

2.  Soluble HER3 predicts survival in bladder cancer patients.

Authors:  Ashfaque A Memon; Stephen C Gilliver; Michael Borre; Jan Sundquist; Kristina Sundquist; Ebba Nexo; Boe S Sorensen
Journal:  Oncol Lett       Date:  2017-11-22       Impact factor: 2.967

3.  The membrane-anchoring domain of epidermal growth factor receptor ligands dictates their ability to operate in juxtacrine mode.

Authors:  Jianying Dong; Lee K Opresko; William Chrisler; Galya Orr; Ryan D Quesenberry; Douglas A Lauffenburger; H Steven Wiley
Journal:  Mol Biol Cell       Date:  2005-04-13       Impact factor: 4.138

4.  The proliferative effects of retinoic acid on primary cultures of adult rat type II pneumocytes depend upon cell density.

Authors:  Richard C Baybutt; Brendon W Smith; Elena V Donskaya; Ling Hu; Ting Li; Weiqun Wang
Journal:  In Vitro Cell Dev Biol Anim       Date:  2009-09-29       Impact factor: 2.416

5.  System theoretical investigation of human epidermal growth factor receptor-mediated signalling.

Authors:  Y Zhang; H Shankaran; L Opresko; H Resat
Journal:  IET Syst Biol       Date:  2008-09       Impact factor: 1.615

6.  An integrated model of epidermal growth factor receptor trafficking and signal transduction.

Authors:  Haluk Resat; Jonathan A Ewald; David A Dixon; H Steven Wiley
Journal:  Biophys J       Date:  2003-08       Impact factor: 4.033

7.  Hypoxia changes the expression of the epidermal growth factor (EGF) system in human hearts and cultured cardiomyocytes.

Authors:  Mathias Munk; Ashfaque Ahmed Memon; Jens Peter Goetze; Lars Bo Nielsen; Ebba Nexo; Boe Sandahl Sorensen
Journal:  PLoS One       Date:  2012-07-05       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.